Guidelines Should Urge Drug Makers to Explain Solo-Wholesaler Decisions: Panel Members

September 29, 2023
Ryukaikon Meeting on September 28 Pharma companies should explain why they chose a single-wholesaler model for certain products when such decisions are made, and this rule should be specified in the health ministry’s commercial guidelines, members of a key distribution...read more